Q2 and H1 saw strong organic growth in revenue, operating income, and EPS, led by smoke-free products and robust combustible performance. Guidance for the full year is maintained, with increased investment in the U.S. and continued margin expansion. ZYN and IQOS drive growth amid regulatory and market shifts.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.